A Method for Gene‐Based Pathway Analysis Using Genomewide Association Study Summary Statistics Reveals Nine New Type 1 Diabetes Associations
Year: 2014
Type: review
Abstract: Pathway analysis can complement point-wise single nucleotide polymorphism (SNP) analysis in exploring genomewide association study (GWAS) data to identify specific disease-associated genes that can be candidate causal genes. We propose a straightforward methodology that can be used for conducting a gene-based pathway analysis using summary GWAS statistics in combination with widely available reference genotype data. We used this method to perform a gene-based pathway analysis of a type 1 diabetes (T1D) meta-analysis GWAS (of 7,514 cases and 9,045 controls). An important feature of the conducted analysis is the removal of the major histocompatibility complex gene region, the major genetic risk factor for T1D. Thirty-one of the 1,583 (2%) tested pathways were identified to be enriched for association with T1D at a 5% false discovery rate. We analyzed these 31 pathways and their genes to identify SNPs in or near these pathway genes that showed potentially novel association with T1D and attempted to replicate the association of 22 SNPs in additional samples. Replication P-values were skewed (P=9.85×10-11) with 12 of the 22 SNPs showing P<0.05. Support, including replication evidence, was obtained for nine T1D associated variants in genes ITGB7 (rs11170466, P=7.86×10-9), NRP1 (rs722988, 4.88×10-8), BAD (rs694739, 2.37×10-7), CTSB (rs1296023, 2.79×10-7), FYN (rs11964650, P=5.60×10-7), UBE2G1 (rs9906760, 5.08×10-7), MAP3K14 (rs17759555, 9.67×10-7), ITGB1 (rs1557150, 1.93×10-6), and IL7R (rs1445898, 2.76×10-6). The proposed methodology can be applied to other GWAS datasets for which only summary level data are available.
Source: Genetic Epidemiology
DOI: 10.1002/gepi.21853
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,854
Funders: Massachusetts General Hospital, University of Pennsylvania, Emory University, Northwestern University, University of Pittsburgh, Louisiana State University, Juvenile Diabetes Research Foundation United Kingdom, Juvenile Diabetes Research Foundation United States of America, Wellcome Trust, National Institute for Health and Care Research, Diabetes UK, National Institutes of Health, School of Medicine, Emory University, Medical Research Council, Cambridge Institute for Medical Research, University of Cambridge, NIHR Cambridge Biomedical Research Centre, National Institute of Mental Health, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development
Awards: G1137313802, G1167720138, G121025920, NIHR Senior Investigator Award, Diabetes and Inflammation Laboratory., G3153491656, Molecular Genetics of Schizophrenia, G3356130012, JDRF/WT Diabetes and Inflammation Laboratory., Molecular Genetics of Schizophrenia, Genes and Pathways in Type 1 Diabetes., G4273598029, Molecular Genetics of Schizophrenia, G4395423461, Molecular Genetics of Schizophrenia, Cellular Medicine at the Cambridge Institute for Medical Research., Molecular Genetics of Schizophrenia, Genetic Determinants of Bipolar Disorder, G5233094584, NIHR Senior Investigator Award, G5568298347, G569302505, Molecular Genetics of Schizophrenia, G5749418015, Molecular Genetics of Schizophrenia, Type 1 Diabetes Genetics Consortium, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, G7256900478, G8052890905, Susceptibility Genes in Type 1 Diabetes, Molecular Genetics of Schizophrenia, The genetics of weight, BMI, adiposity and obesity, Design and implementation of large-scale genetic association studies of commondiseases.
OpenAlex ID: W2042786321
